Antonios Pipis und Expert Opinion - Info zur Person

(1 - 11 von 12

)

Emerging drugs for diabetic retinopathyScholars Portal Journals

journals.scholarsportal.info

Authors. Antonios Pipis · Stefan Scholl · Albert J Augustin. Source Information. December 2011, Volume16(Issue4)Pages, p.669To Expert Opinion on ... Authors. Antonios Pipis · Stefan Scholl · Albert J Augustin. Source Information. December 2011, Volume16(Issue4)Pages, p.669To Expert Opinion on ...

Expert Opinion on Emerging DrugsScholars Portal Journals

journals.scholarsportal.info

Antonios Pipis · Stefan Scholl · Albert J Augustin. Source Information. December 2011, Volume16(Issue4)Pages, p.669To Abstract. Introduction: Diabetes ... Antonios Pipis · Stefan Scholl · Albert J Augustin. Source Information. December 2011, Volume16(Issue4)Pages, p.669To Abstract. Introduction: Diabetes ...

Expert Opinion on Emerging Drugs, Volume 16, Issue 4 (2011)Taylor & Francis Online

www.tandfonline.com

Antonios Pipis MD, Stefan Scholl MD & Albert J Augustin MD. Pages: Published online: 23 Nov AbstractforEmerging drugs for diabetic retinopathy ... Antonios Pipis MD, Stefan Scholl MD & Albert J Augustin MD. Pages: Published online: 23 Nov AbstractforEmerging drugs for diabetic retinopathy ...

SpringerCitations - Details Page

citations.springernature.com

Emerging drugs for diabetic retinopathy. Antonios Pipis, Stefan Scholl and Albert J Augustin. Journal: Expert Opinion on Emerging Drugs, 2011, Volume 16, ...

Five-Year Patterns of Diabetic Retinopathy Progression in US ...

www.tandfonline.com

von A Moshfeghi · · Zitiert von: 15 — Antonios Pipis et al. Expert Opinion on Emerging Drugs. Published online: 24 Dec Full Access. View more ... › abs

Alle Infos zum Namen "Antonios Pipis"

Expert Opinion on Emerging Drugs, Volume 16, Issue 4 (2011)Taylor & Francis Online

www.informahealthcare.com

0Altmetric. Full Access. Review Article. Emerging drugs for diabetic retinopathy · xml · Antonios Pipis MD, Stefan Scholl MD & Albert J Augustin MD. Pages: Altmetric. Full Access. Review Article. Emerging drugs for diabetic retinopathy · xml · Antonios Pipis MD, Stefan Scholl MD & Albert J Augustin MD. Pages:

Emerging drugs for diabetic retinopathy.Sigma-Aldrich

www.sigmaaldrich.id

— Emerging drugs for diabetic retinopathy. by Antonios Pipis, Stefan Scholl, Albert J Augustin. Expert opinion on emerging drugs — Emerging drugs for diabetic retinopathy. by Antonios Pipis, Stefan Scholl, Albert J Augustin. Expert opinion on emerging drugs.

Verwandte Suchanfragen zu Antonios Pipis

Personen
Vorname "Antonios" (420)
Name "Pipis" (10)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Antonios Pipis und Expert Opinion Person-Info

Emerging drugs for diabetic retinopathyScholars Portal Journals

Expert Opinion on Emerging DrugsScholars Portal Journals

Expert Opinion on Emerging Drugs, Volume 16, Issue 4 (2011)Taylor & Francis Online

SpringerCitations - Details Page

Five-Year Patterns of Diabetic Retinopathy Progression in US ...

Alle Infos zum Namen "Antonios Pipis"

Expert Opinion on Emerging Drugs, Volume 16, Issue 4 (2011)Taylor & Francis Online

Emerging drugs for diabetic retinopathy.Sigma-Aldrich

F Sigma-Aldrich

Intravitreal Triamcinolone Acetonide for Diabetic Macular ...Mary Ann Liebert

Expert Opinion on Emerging Drugs, Volume 16, Issue 4 (2011)

Emerging drugs for diabetic retinopathy | Read by QxMD